Evidence map›Paper›PMID 30851093›Full record

ArticleBioinformatics (Oxford, England)2019

Interoperable and scalable data analysis with microservices: applications in metabolomics.

Payam Emami Khoonsari, Pablo Moreno, Sven Bergmann, Joachim Burman, Marco Capuccini, Matteo Carone, Marta Cascante, Pedro de Atauri, Carles Foguet, Alejandra N Gonzalez-Beltran and 25 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Tackling the Challenges of 21Patterns (New York, N.Y.) · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Experience in Developing an FHIR Medical Data Management Platform to Provide Clinical Decision Support.International journal of environmental research and public health · 2019
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Payam Emami KhoonsariDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Pablo MorenoEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Sven BergmannDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Joachim BurmanDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Marco CapucciniDepartment of Information Technology, Uppsala University, Uppsala, Sweden.
Matteo CaroneDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Marta CascanteDepartment of Biochemistry and Molecular Biomedicine, and Institute of Biomedicine (IBUB), Faculty of Biology, Universitat de Barcelona (IBUB), Barcelona, Spain.
Pedro de AtauriDepartment of Biochemistry and Molecular Biomedicine, and Institute of Biomedicine (IBUB), Faculty of Biology, Universitat de Barcelona (IBUB), Barcelona, Spain.
Carles FoguetDepartment of Biochemistry and Molecular Biomedicine, and Institute of Biomedicine (IBUB), Faculty of Biology, Universitat de Barcelona (IBUB), Barcelona, Spain.
Alejandra N Gonzalez-BeltranOxford e-Research Centre, Department of Engineering Science, University of Oxford, Oxford, UK.
Thomas HankemeierDivision of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Kenneth HaugEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Sijin HeEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Stephanie HermanDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
David JohnsonOxford e-Research Centre, Department of Engineering Science, University of Oxford, Oxford, UK.
Namrata KaleEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Anders LarssonDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Steffen NeumannDepartment of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle, Germany.
Kristian PetersDepartment of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle, Germany.
Luca PiredduCRS4: Center for Advanced Studies, Research and Development in Sardinia, Distributed Computing Group, Pula, Italy.
Philippe Rocca-SerraOxford e-Research Centre, Department of Engineering Science, University of Oxford, Oxford, UK.
Pierrick RogerCEA, LIST, Laboratory for Data Analysis and Systems' Intelligence, MetaboHUB, Gif-sur-Yvette, France.
Rico RueediDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Christoph RuttkiesDepartment of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle, Germany.
Noureddin SadawiFaculty of Medicine, Department of Surgery & Cancer, Imperial College London, London, UK.
Reza M SalekInternational Agency for Research on Cancer, 69372 Lyon CEDEX 08, France.
Susanna-Assunta SansoneOxford e-Research Centre, Department of Engineering Science, University of Oxford, Oxford, UK.
Daniel SchoberDepartment of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle, Germany.
Vitaly SelivanovDepartment of Biochemistry and Molecular Biomedicine, and Institute of Biomedicine (IBUB), Faculty of Biology, Universitat de Barcelona (IBUB), Barcelona, Spain.
Etienne A ThévenotCEA, LIST, Laboratory for Data Analysis and Systems' Intelligence, MetaboHUB, Gif-sur-Yvette, France.
Michael van VlietDivision of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Gianluigi ZanettiCRS4: Center for Advanced Studies, Research and Development in Sardinia, Distributed Computing Group, Pula, Italy.
Christoph SteinbeckEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Kim KultimaDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Ola SpjuthDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

Funding

Biotechnology and Biological Sciences Research Council BB/H024921/1Biotechnology and Biological Sciences Research Council BB/I000771/1Biotechnology and Biological Sciences Research Council BB/L024055/1World Health Organization 001
6 · The paper itself

Abstract

motivationDeveloping a robust and performant data analysis workflow that integrates all necessary components whilst still being able to scale over multiple compute nodes is a challenging task. We introduce a generic method based on the microservice architecture, where software tools are encapsulated as Docker containers that can be connected into scientific workflows and executed using the Kubernetes container orchestrator.

resultsWe developed a Virtual Research Environment (VRE) which facilitates rapid integration of new tools and developing scalable and interoperable workflows for performing metabolomics data analysis. The environment can be launched on-demand on cloud resources and desktop computers. IT-expertise requirements on the user side are kept to a minimum, and workflows can be re-used effortlessly by any novice user. We validate our method in the field of metabolomics on two mass spectrometry, one nuclear magnetic resonance spectroscopy and one fluxomics study. We showed that the method scales dynamically with increasing availability of computational resources. We demonstrated that the method facilitates interoperability using integration of the major software suites resulting in a turn-key workflow encompassing all steps for mass-spectrometry-based metabolomics including preprocessing, statistics and identification. Microservices is a generic methodology that can serve any scientific discipline and opens up for new types of large-scale integrative science. AVAILABILITY AND IMPLEMENTATION: The PhenoMeNal consortium maintains a web portal (https://portal.phenomenal-h2020.eu) providing a GUI for launching the Virtual Research Environment. The GitHub repository https://github.com/phnmnl/ hosts the source code of all projects. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Data AnalysisMetabolomicsComputational BiologySoftwareWorkflow

Identifiers

PMID30851093
PMCPMC6761976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.